182 related articles for article (PubMed ID: 33042621)
1. Metformin activates the STING/IRF3/IFN-β pathway by inhibiting AKT phosphorylation in pancreatic cancer.
Ren D; Qin G; Zhao J; Sun Y; Zhang B; Li D; Wang B; Jin X; Wu H
Am J Cancer Res; 2020; 10(9):2851-2864. PubMed ID: 33042621
[TBL] [Abstract][Full Text] [Related]
2. SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma.
Wu W; Zhang Z; Jing D; Huang X; Ren D; Shao Z; Zhang Z
Cell Death Dis; 2022 Jun; 13(6):523. PubMed ID: 35662245
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context.
Czapla J; Drzyzga A; Matuszczak S; Cichoń T; Rusin M; Jarosz-Biej M; Pilny E; Smolarczyk R
Front Oncol; 2023; 13():1249524. PubMed ID: 37655095
[TBL] [Abstract][Full Text] [Related]
4. STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer.
Vonderhaar EP; Barnekow NS; McAllister D; McOlash L; Eid MA; Riese MJ; Tarakanova VL; Johnson BD; Dwinell MB
Cell Mol Gastroenterol Hepatol; 2021; 12(1):41-58. PubMed ID: 33548597
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of STING Agonist cGAMP with Folic Acid-Conjugated Liposomes Significantly Enhances Antitumor Pharmacodynamic Effect.
Lu X; Cheng H; Xu Q; Tan X
Cancer Biother Radiopharm; 2023 Oct; 38(8):543-557. PubMed ID: 33719535
[No Abstract] [Full Text] [Related]
6. STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer.
Da Y; Liu Y; Hu Y; Liu W; Ma J; Lu N; Zhang C; Zhang C
Oncoimmunology; 2022; 11(1):2054105. PubMed ID: 35371622
[TBL] [Abstract][Full Text] [Related]
7. Metformin promotes cGAS/STING signaling pathway activation by blocking AKT phosphorylation in gastric cancer.
Shen Q; Yang L; Li C; Wang T; Lv J; Liu W; Lin Y; Yin Y; Tao K
Heliyon; 2023 Aug; 9(8):e18954. PubMed ID: 37600406
[TBL] [Abstract][Full Text] [Related]
8. An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer.
An X; Zhu Y; Zheng T; Wang G; Zhang M; Li J; Ji H; Li S; Yang S; Xu D; Li Z; Wang T; He Y; Zhang L; Yang W; Zhao R; Hao D; Li X
Mol Ther Nucleic Acids; 2019 Mar; 14():80-89. PubMed ID: 30583098
[TBL] [Abstract][Full Text] [Related]
9. Activation of STING in the pancreatic tumor microenvironment: A novel therapeutic opportunity.
Chamma H; Vila IK; Taffoni C; Turtoi A; Laguette N
Cancer Lett; 2022 Jul; 538():215694. PubMed ID: 35489447
[TBL] [Abstract][Full Text] [Related]
10. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway.
Wang S; Böhnert V; Joseph AJ; Sudaryo V; Swinderman J; Yu FB; Lyu X; Skariah G; Subramanyam V; Gilbert LA; Goodarzi H; Lingyin L
bioRxiv; 2023 Jun; ():. PubMed ID: 37333273
[TBL] [Abstract][Full Text] [Related]
11. STING activator 2'3'-cGAMP enhanced HSV-1-based oncolytic viral therapy.
Sibal PA; Matsumura S; Ichinose T; Bustos-Villalobos I; Morimoto D; Eissa IR; Abdelmoneim M; Aboalela MAM; Mukoyama N; Tanaka M; Naoe Y; Kasuya H
Mol Oncol; 2024 May; 18(5):1259-1277. PubMed ID: 38400597
[TBL] [Abstract][Full Text] [Related]
12. A sequential scheme including PTT and 2'3'-cGAMP/CQ-LP reveals the antitumor immune function of PTT through the type I interferon pathway.
Song X; Wang M; Liu S; Liu H; Jiang A; Zou Y; Deng Y; Qin Q; Song Y; Zheng Y
Pharmacol Res; 2023 Oct; 196():106939. PubMed ID: 37758101
[TBL] [Abstract][Full Text] [Related]
13. Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.
Zhou G; Yu J; Wang A; Liu SH; Sinnett-Smith J; Wu J; Sanchez R; Nemunaitis J; Ricordi C; Rozengurt E; Brunicardi FC
Curr Mol Med; 2016; 16(1):83-90. PubMed ID: 26695692
[TBL] [Abstract][Full Text] [Related]
14. Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3.
Zhang D; Su C; Zheng C
J Virol; 2016 Jun; 90(12):5824-5829. PubMed ID: 27076640
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional STING-Activating Mn
Zhou M; Wang X; Lin S; Cheng Y; Zhao S; Lin J; Fang Z; Lou Z; Qin L; Wei H
Adv Healthc Mater; 2020 Jul; 9(13):e2000064. PubMed ID: 32484320
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.
Yuen CK; Chan CP; Fung SY; Wang PH; Wong WM; Tang HV; Yuen KS; Chan CP; Jin DY; Kok KH
J Virol; 2016 Apr; 90(8):3902-3912. PubMed ID: 26819312
[TBL] [Abstract][Full Text] [Related]
17. Activation of STING by cGAMP Regulates MDSCs to Suppress Tumor Metastasis
Cheng H; Xu Q; Lu X; Yuan H; Li T; Zhang Y; Tan X
Front Oncol; 2020; 10():896. PubMed ID: 32596152
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.
Ohkuri T; Kosaka A; Ishibashi K; Kumai T; Hirata Y; Ohara K; Nagato T; Oikawa K; Aoki N; Harabuchi Y; Celis E; Kobayashi H
Cancer Immunol Immunother; 2017 Jun; 66(6):705-716. PubMed ID: 28243692
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
20. MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell-intrinsic Amplification of Type I IFN Signaling.
Ghukasyan R; Liang K; Chau K; Li L; Chan C; Abt ER; Le T; Park JY; Wu N; Premji A; Damoiseaux R; Luu T; Labora A; Rashid K; Link JM; Radu CG; Donahue TR
Clin Cancer Res; 2023 Aug; 29(16):3130-3141. PubMed ID: 37195712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
